UPS Stock Forecast: Is the 6.9% Dividend Too Good to Be True?
Parcel delivery giant UPS (NYSE:UPS) has seen its fair share…
Sell
12
BTAI Quote, Financials, Valuation and Earnings
Last price:
$1.38
Seasonality move
:
-33.11%
Day range:
$1.30 - $1.42
52-week range:
$1.29 - $30.88
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.45x
P/B ratio:
--
Volume:
105.6K
Avg. volume:
93.6K
1-year change:
-95.3%
Market cap:
$8.4M
Revenue:
$2.3M
EPS (TTM):
-$13.55
Earnings Data
Next earnings date for BTAI
Aug 06
2025
Most recent earnings per share
-$1.50
Beat by $1.54
(May 12/2025)
Consensus Estimate
-$3.04
(May 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
BTAI Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/06/2025 | Q2 | $400K | -- | -- | -$2.16 | -- |
| 05/12/2025 | Q1 | $350K | $168K | -$1.50 | -$3.04 | $1.54 |
| 03/27/2025 | Q4 | $718.3K | $366K | -$3.57 | -$5.14 | $1.57 |
| 11/14/2024 | Q3 | $1.3M | $214K | -$5.12 | -$7.68 | $2.56 |
| 08/06/2024 | Q2 | $1.1M | $1.1M | -$3.36 | -$10.99 | $7.63 |
| 05/09/2024 | Q1 | $632.6K | $582K | -$13.92 | -$11.52 | -$2.40 |
| 03/12/2024 | Q4 | $741.3K | $376K | -$12.16 | -$12.72 | $0.56 |
| 11/14/2023 | Q3 | $626K | $341K | -$27.52 | -$20.00 | -$7.52 |
| 08/14/2023 | Q2 | $466.9K | $457K | -$29.28 | -$27.68 | -$1.60 |
| 05/08/2023 | Q1 | $323.8K | $206K | -$29.44 | -$25.37 | -$4.07 |
| 03/09/2023 | Q4 | -- | $238K | -$31.20 | -- | -- |
| 11/10/2022 | Q3 | -- | $137K | -$23.84 | -- | -- |
| 08/09/2022 | Q2 | -- | -- | -$21.60 | -- | -- |
| 05/09/2022 | Q1 | -- | -- | -$17.92 | -- | -- |
| 03/10/2022 | Q4 | -- | -- | -$14.88 | -- | -- |
| 11/10/2021 | Q3 | -- | -- | -$15.36 | -- | -- |
| 08/10/2021 | Q2 | -- | -- | -$17.76 | -- | -- |
| 05/10/2021 | Q1 | -- | -- | -$17.28 | -- | -- |
| 03/11/2021 | Q4 | -- | -- | -$13.92 | -- | -- |
| 11/12/2020 | Q3 | -- | -- | -$17.12 | -- | -- |
| 08/14/2020 | Q2 | -- | -- | -$16.96 | -- | -- |
| 05/12/2020 | Q1 | -- | -- | -$12.64 | -- | -- |
| 03/09/2020 | Q4 | -- | -- | -$7.20 | -- | -- |
| 11/14/2019 | Q3 | -- | -- | -$9.12 | -- | -- |
| 08/06/2019 | Q2 | -- | -- | -$8.64 | -- | -- |
| 05/07/2019 | Q1 | -- | -- | -$7.36 | -- | -- |
| 03/07/2019 | Q4 | -- | -- | -$7.36 | -- | -- |
| 11/09/2018 | Q3 | -- | -- | -$4.96 | -- | -- |
| 08/08/2018 | Q2 | -- | -- | -$3.04 | -- | -- |
| 05/14/2018 | Q1 | -- | -- | -$5.92 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$2.66 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$0.94 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$0.58 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$0.54 | -- | -- |
BioXcel Therapeutics Earnings Questions
-
How Much did BioXcel Therapeutics Generate in Revenue Last Quarter?
BioXcel Therapeutics reported $168K worth of top line sales in its most recent quarter.
-
Did BioXcel Therapeutics Beat Earnings Last Quarter?
BioXcel Therapeutics announced earnings per share of -$1.50 which represents a beat of analyst forecast a -$3.04 per share.
-
Is BioXcel Therapeutics Profitable?
BioXcel Therapeutics reported $154K that represents $0.03 per share over the last quarter.
-
What is the Analyst Consensus for BioXcel Therapeutics EPS Next Year?
BioXcel Therapeutics's earnings are forecast to decrease from -$23.51 per share to -$25.33 per share next year representing a decrease of -61%.
-
When is BioXcel Therapeutics's Earnings Date?
BioXcel Therapeutics's next earnings date is August 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Coinbase Stock Be in 5 Years?
If you’ve been anywhere near the crypto world over the…
How High Will Planet Labs Stock Go in 2025?
Today we dive into Planet Labs (NYSE: PL), the satellite…
Stock Ideas
Buy
65
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 38x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 45x
Sell
33
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Alerts
Buy
55
SBET alert for May 27
SharpLink Gaming [SBET] is up 454.46% over the past day.
Buy
60
MRUS alert for May 27
Merus NV [MRUS] is down 7.93% over the past day.
Buy
57
RGC alert for May 27
Regencell Bioscience Holdings [RGC] is down 9.77% over the past day.
